In the past, a Cochrane review on antiplatelet therapy after SAH showed a nonsignificant trend toward a lower occurrence of DCI and improved clinical outcome but was possibly offset by a concomitant nonsignificant increase in hemorrhagic complications [ 25 ].
← all excerpts
The Discriminative Ability of ROTEM for Delayed Cerebral Ischemia and Poor Outcome Following Aneurysmal Subarachnoid Hemorrhage.
1
—
—